Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV000660650 | SCV000782777 | uncertain significance | Developmental and epileptic encephalopathy, 13; Seizures, benign familial infantile, 5 | 2018-02-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001493054 | SCV001697676 | likely benign | Early infantile epileptic encephalopathy with suppression bursts | 2024-04-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002334226 | SCV002635245 | uncertain significance | Inborn genetic diseases | 2017-07-18 | criteria provided, single submitter | clinical testing | The p.T1545I variant (also known as c.4634C>T), located in coding exon 25 of the SCN8A gene, results from a C to T substitution at nucleotide position 4634. The threonine at codon 1545 is replaced by isoleucine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |